MK-3614

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-3614, covering 2019-08-08 to 2021-05-03. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Dose Study of MK-3614 (MK-3614-002) [Phase 1]